The Epstein-Barr virus and its association with human cancers.
about
Herpesvirus pan encodes a functional homologue of BHRF1, the Epstein-Barr virus v-Bcl-2The Role of Gammaherpesviruses in Cancer PathogenesisBiomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiationLatent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccinesEarly events associated with infection of Epstein-Barr virus infection of primary B-cellsThe distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer typesCharacteristics of Epstein-Barr virus envelope protein gp42.Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.Molecular pathways in virus-induced cytokine production.The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis.Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinomaLMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells.Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells.Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literature.Evaluation of Epstein-Barr virus latent membrane protein 2 specific T-cell receptors driven by T-cell specific promoters using lentiviral vectorAutoimmune haemolytic anaemia associated with Epstein Barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report.Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblastsGammaherpesvirus Infection of Human Neuronal Cells.Epstein-Barr virus BGLF4 kinase downregulates NF-κB transactivation through phosphorylation of coactivator UXT.Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.Epstein-Barr virus in human malignancy: a special reference to Epstein-Barr virus associated gastric carcinoma.Epstein-Barr virus: novel patented therapeutics.Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature.Structural and functional distinctiveness of HLA-A2 allelic variants.Epstein-Barr virus strains and variations: Geographic or disease-specific variants?Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma.Human monocytic cell lines transformed in vitro by Epstein-Barr virus display a type II latency and LMP-1-dependent proliferation.Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion.Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantationResolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation.Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus.Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation.EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness.Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal.Overexpression of Activation-Induced Cytidine Deaminase in MTX- and Age-Related Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders of the Head and Neck.Themed issue: the biology and pathology of the Epstein-Barr virus.Modification of Cepsilon mRNA expression by EBV-encoded latent membrane protein 1.Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1.
P2860
Q24804111-2C6CD859-F3B0-4491-A436-A58E20B5BC51Q26767186-AFBA8EA0-355D-4031-A59C-6AD5BD74A9B5Q27010624-09ED4BC3-EBB6-49CA-9188-404512D2010DQ27497985-95155C45-0512-43AB-9D9F-D069CB8AD79BQ28476230-991F9E90-4D90-4BFD-BE4B-77154A7635B5Q33389641-677B17DB-5840-49CA-A0F1-1167A114AB21Q33790326-03355702-8E3D-48F9-9FB3-D2E84EBBDADBQ33866046-86DB3A69-0D37-42DF-A39A-1012CF6E3160Q33884691-BFCE844C-6191-4C92-A28A-21A7A29F89EAQ34174972-C117185D-0DC0-4203-A5B2-AAABE69E6D32Q34275895-7CD2FEBC-3DD5-4AF2-AF93-7EF6F2AB30AFQ34365798-08CF9B3D-401F-4466-8243-C7D8F2D3EBDEQ34430225-983829AC-2B18-40FB-A1D2-E6E9F4FB664BQ34507851-B899782E-ED43-48A9-A020-D24F3440AF41Q35198931-C214FE4C-5483-4443-9725-D459011EFB20Q35238310-A6811248-2FC5-4300-B6AC-274F0E17570DQ35695586-1252A75B-9B66-41B9-9223-A3E833A3DAF8Q36207171-A969BA64-A584-41CE-A3FA-8C0F0FCB4AA5Q36346036-AACF808F-F77E-45F6-A7B9-EC66A31C3170Q36363901-4BA18822-188D-4B7C-B071-52AD9E3599ACQ37092673-3A97A286-B922-49A1-B9EB-E05358D70FD2Q37449248-282CDA45-2587-40B5-B1E3-ED68D5621226Q37729167-AC79C433-57AF-4CF9-9A3F-B629CDA30AC0Q37860045-8B894030-E80D-4826-8D81-7CE2C90D09F2Q37995559-56963FB9-C8B3-458F-8E62-8D80B3588E10Q38901360-C3F54C55-19EC-424F-837D-8B905D1BFCE9Q39170011-351BE35B-3659-4930-AB69-38A9DB0FE06BQ39202093-CD110CE4-8EAA-4522-AC2A-372C289FEBC8Q39683879-DE7A39EB-3B3B-4F2F-96E6-322009D8D85FQ40041237-FCDE3540-EEDC-4856-9285-0EDA923BA813Q40336926-F4694AC5-5CAE-4648-8ED0-0170B505E5BAQ40421062-AD5D18B6-877F-4A1C-AF63-FC454196D038Q40487893-C91539ED-3C97-4E3E-9C08-FF05FD304ECEQ40584058-0700C821-15C7-4A5A-9D43-EFA124F78BE5Q40718647-A2C4CC55-BC74-498A-A719-0AFE93632165Q41328752-C4024667-F15E-4F17-A62D-F7E89623E1A3Q42151073-71A7DF7F-C76D-4BCC-9DBC-E5F346CEB4C8Q42937204-18AD8EBE-D609-4644-8332-3979183941D1Q43003742-3F6A5A04-0808-4D67-BDC2-7043C9AFBF13Q44605546-28A97F96-9925-4CA9-83F7-93F959E93E3A
P2860
The Epstein-Barr virus and its association with human cancers.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The Epstein-Barr virus and its association with human cancers.
@ast
The Epstein-Barr virus and its association with human cancers.
@en
type
label
The Epstein-Barr virus and its association with human cancers.
@ast
The Epstein-Barr virus and its association with human cancers.
@en
prefLabel
The Epstein-Barr virus and its association with human cancers.
@ast
The Epstein-Barr virus and its association with human cancers.
@en
P2093
P2860
P356
P1476
The Epstein-Barr virus and its association with human cancers.
@en
P2093
Baumforth KR
Constandinou C
Flavell KJ
P2860
P304
P356
10.1136/MP.52.6.307
P407
P577
1999-12-01T00:00:00Z